share_log

Those Who Invested in HealthEquity (NASDAQ:HQY) Three Years Ago Are up 97%

Those Who Invested in HealthEquity (NASDAQ:HQY) Three Years Ago Are up 97%

三年前投資HealthEquity(納斯達克:HQY)的人收益增長了97%
Simply Wall St ·  01/06 07:53

By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger returns, and build a portfolio ourselves. For example, HealthEquity, Inc. (NASDAQ:HQY) shareholders have seen the share price rise 97% over three years, well in excess of the market return (21%, not including dividends). On the other hand, the returns haven't been quite so good recently, with shareholders up just 36%.

通過購買指數基金,投資者可以接近市場的平均回報。但我們中的很多人敢於夢想更高的回報,並自己構建投資組合。例如,HealthEquity, Inc. (納斯達克:HQY)的股東在三年內看到股價上漲了97%,遠遠超過市場回報(21%,不包括分紅派息)。另一方面,最近的回報並不是很好,股東的收益僅爲36%。

So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns.

那麼讓我們評估過去三年的基本面,看看它們是否與股東回報同向移動。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

雖然有效市場假說仍然會被一些人教授,但已經證明市場是過度反應的動態系統,投資者並不總是理性的。考察市場情緒隨時間變化的一種方法是查看公司股價與每股收益(EPS)之間的互動。

HealthEquity became profitable within the last three years. So we would expect a higher share price over the period.

HealthEquity在過去三年內實現了盈利。因此我們期望在此期間股價會更高。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

您可以在下面看到EPS如何隨時間變化(點擊圖片可以發現具體數值)。

big
NasdaqGS:HQY Earnings Per Share Growth January 6th 2025
納斯達克GS:HQY 每股收益增長 2025年1月6日

We know that HealthEquity has improved its bottom line over the last three years, but what does the future have in store? This free interactive report on HealthEquity's balance sheet strength is a great place to start, if you want to investigate the stock further.

我們知道HealthEquity在過去三年中改善了其底線,但未來會如何呢?如果您想進一步調查這隻股票,這份關於HealthEquity財務狀況的免費互動報告是一個很好的起點。

A Different Perspective

不同的視角

It's good to see that HealthEquity has rewarded shareholders with a total shareholder return of 36% in the last twelve months. That gain is better than the annual TSR over five years, which is 6%. Therefore it seems like sentiment around the company has been positive lately. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for HealthEquity that you should be aware of before investing here.

很高興看到HealthEquity在過去12個月中給股東帶來了36%的總股東回報。這一增益優於五年的年 TSR(總股東回報),爲6%。因此,似乎對公司的情緒最近一直是積極的。持樂觀觀點的人可能會將最近的 TSR 改善視爲表明業務本身隨着時間的推移在改善。儘管考慮市場狀況對股價的不同影響是非常值得的,但還有其他因素更爲重要。例如,我們發現了2個關於HealthEquity的警示信號,在此投資之前要注意這些信號。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,你可能會通過其他地方尋找一個絕佳的投資機會。所以請查看這個我們預計將增長每股收益的公司免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文中引用的市場回報反映了當前在美國交易所上市股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論